Search hospitals
>
Michigan
>
Grand Rapids
Helen DeVos Children's Hospital at Spectrum Health
Claim this profile
Grand Rapids, Michigan 49503
Global Leader in Cancer
Global Leader in Neuroblastoma
Conducts research for Brain Tumor
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Solid Tumors
333 reported clinical trials
8 medical researchers
Summary
Helen DeVos Children's Hospital at Spectrum Health is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Neuroblastoma, Brain Tumor, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Helen DeVos Children's Hospital at Spectrum Health is involved with conducting 333 clinical trials across 584 conditions. There are 8 research doctors associated with this hospital, such as Kathleen J. Yost, Troy Quigg, DO, David Hoogstra, and Deanna Mitchell, MD.
Area of expertise
Cancer
Helen DeVos Children's Hospital at Spectrum Health has run 52 trials for Cancer. Some of their research focus areas include:
Neuroblastoma
Helen DeVos Children's Hospital at Spectrum Health has run 45 trials for Neuroblastoma. Some of their research focus areas include:
Top PIs
Kathleen J. Yost
Bronson Methodist Hospital
8 years of reported clinical research
Troy Quigg, DO
Helen DeVos Children's Hospital
7 years of reported clinical research
David Hoogstra
Helen DeVos Children's Hospital
1 year of reported clinical research
Deanna Mitchell, MD
Helen DeVos Children's Hospital
5 years of reported clinical research
Clinical Trials running at Helen DeVos Children's Hospital at Spectrum Health
Multiple Myeloma
Lung Cancer
Melanoma
Acute Lymphoblastic Leukemia
Neuroblastoma
Leukemia
Cutaneous Melanoma
Testicular cancer
Cancer
Breast Cancer
Drug Combinations
for Multiple Myeloma
This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on age, comorbidities, and functional status. Treatment for multiple myeloma includes initial treatment (induction) which is the first treatment a patient receives for cancer followed by ongoing treatment (maintenance) which is given after initial treatment to help keep the cancer from coming back. There are three combinations of four different drugs being studied. Bortezomib is one of the drugs that may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide works by helping bone marrow to produce normal blood cells and killing cancer cells. Anti-inflammatory drugs, such as dexamethasone, lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Daratumumab and hyaluronidase-fihj is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Patients receive 1 of 3 combinations of these drugs for treatment to determine which combination of study drugs works better to shrink and control multiple myeloma.
Recruiting
2 awards
Phase 3
21 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting
2 awards
Phase 3
12 criteria
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting
2 awards
Phase 3
32 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Helen DeVos Children's Hospital at Spectrum Health?
Helen DeVos Children's Hospital at Spectrum Health is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Cancer, Neuroblastoma, Brain Tumor, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Helen DeVos Children's Hospital at Spectrum Health is involved with conducting 333 clinical trials across 584 conditions. There are 8 research doctors associated with this hospital, such as Kathleen J. Yost, Troy Quigg, DO, David Hoogstra, and Deanna Mitchell, MD.
Where is Helen DeVos Children's Hospital at Spectrum Health located?
Helen DeVos Children's Hospital at Spectrum Health, situated in downtown Grand Rapids, Michigan, at 100 Michigan St. NE, Grand Rapids, MI 49503, is a leading freestanding children's hospital. It boasts over 300 pediatric specialists and subspecialists across more than 50 pediatric specialties and programs. The hospital is acclaimed by U.S. News & World Report as a Best Children's Hospital, highlighting its commitment to providing expert pediatric care.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance at Helen DeVos Children's Hospital:** - For financial assistance, contact the department at 844.838.3115 to determine eligibility and explore payment options. - Apply for assistance using the Confidential Financial Assistance Application, available in multiple languages. - For application assistance or other inquiries, connect with a Lakeland financial counselor at 844.408.4103, available Monday through Friday, 8 a.m. to 4:30 p.m. **Insurance Inquiries:** - For insurance-related questions, contact Spectrum Health for Employers at 616.391..... for detailed information and support.
What insurance does Helen DeVos Children's Hospital at Spectrum Health accept?
Helen DeVos Children's Hospital at Spectrum Health accepts most commercial insurance plans, Medicare, and Medicaid. They contract with a variety of payers including Aetna, Anthem/Blue Cross Blue Shield, Cigna, Humana, UnitedHealthcare Insurance Company, and WellCare Health Plans. Financial Counselors are available to assist with determining individual plan coverage.
What awards or recognition has Helen DeVos Children's Hospital at Spectrum Health received?
Helen DeVos Children's Hospital at Spectrum Health, located in Grand Rapids, Michigan, has been recognized as a Best Children's Hospital by U.S. News & World Report and has earned Magnet Recognition status from the American Nurses Credentialing Center. The hospital's hematology, oncology, and bone marrow transplant program was awarded the American Society of Clinical Oncology Award, distinguishing it as one of only eight hospitals in the U.S. to receive this honor. This follows a successful capital campaign initiated by a $50 million gift from the children of Rich and Helen DeVos, raising a total of $103 million.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.